Effect of Bosentan in Patients With Metastatic Melanoma Treated With Dacarbazine (DTIC)
Clinical trial NCT01009177 · COMPLETED
Trial details
- NCT number
- NCT01009177
- Sponsor
- Actelion
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-30
- Primary completion
- 2008-02-29
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.